Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.
Identifieur interne : 000342 ( Main/Exploration ); précédent : 000341; suivant : 000343Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.
Auteurs : A. Sangil [Espagne] ; E. Calbo ; A. Robles ; S. Benet ; M E Viladot ; V. Pascual ; E. Cuchí ; J. Pérez ; B. Barreiro ; B. Sánchez ; J. Torres ; L. Canales ; J A De Marcos ; J. GarauSource :
- European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [ 1435-4373 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Bordetella pertussis (génétique), Bordetella pertussis (isolement et purification), Chlamydophila pneumoniae (génétique), Chlamydophila pneumoniae (isolement et purification), Co-infection (microbiologie), Co-infection (virologie), Co-infection (épidémiologie), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Indice de gravité de la maladie (MeSH), Infections bactériennes à Gram négatif (microbiologie), Infections bactériennes à Gram négatif (épidémiologie), Infections communautaires (diagnostic), Infections communautaires (microbiologie), Infections communautaires (virologie), Infections communautaires (épidémiologie), Infections à virus respiratoire syncytial (diagnostic), Infections à virus respiratoire syncytial (virologie), Infections à virus respiratoire syncytial (épidémiologie), Legionella pneumophila (génétique), Legionella pneumophila (isolement et purification), Mycoplasma pneumoniae (génétique), Mycoplasma pneumoniae (isolement et purification), Mâle (MeSH), Pandémies (MeSH), Pneumopathie bactérienne (diagnostic), Pneumopathie bactérienne (microbiologie), Pneumopathie bactérienne (épidémiologie), Pneumopathie virale (diagnostic), Pneumopathie virale (virologie), Pneumopathie virale (épidémiologie), Réaction de polymérisation en chaine multiplex (MeSH), Saisons (MeSH), Sous-type H1N1 du virus de la grippe A (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Techniques de typage bactérien (MeSH), Virus respiratoire syncytial humain (isolement et purification), Virus respiratoire syncytial humain (pathogénicité), Études prospectives (MeSH).
- MESH :
- diagnostic : Infections communautaires, Infections à virus respiratoire syncytial, Pneumopathie bactérienne, Pneumopathie virale.
- génétique : Bordetella pertussis, Chlamydophila pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae.
- isolement et purification : Bordetella pertussis, Chlamydophila pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae, Virus respiratoire syncytial humain.
- microbiologie : Co-infection, Infections bactériennes à Gram négatif, Infections communautaires, Pneumopathie bactérienne.
- pathogénicité : Virus respiratoire syncytial humain.
- virologie : Co-infection, Grippe humaine, Infections communautaires, Infections à virus respiratoire syncytial, Pneumopathie virale.
- épidémiologie : Co-infection, Espagne, Grippe humaine, Infections bactériennes à Gram négatif, Infections communautaires, Infections à virus respiratoire syncytial, Pneumopathie bactérienne, Pneumopathie virale.
- Adulte d'âge moyen, Femelle, Humains, Indice de gravité de la maladie, Mâle, Pandémies, Réaction de polymérisation en chaine multiplex, Saisons, Sous-type H1N1 du virus de la grippe A, Sujet âgé, Sujet âgé de 80 ans ou plus, Techniques de typage bactérien, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Bacterial Typing Techniques (MeSH), Bordetella pertussis (genetics), Bordetella pertussis (isolation & purification), Chlamydophila pneumoniae (genetics), Chlamydophila pneumoniae (isolation & purification), Coinfection (epidemiology), Coinfection (microbiology), Coinfection (virology), Community-Acquired Infections (diagnosis), Community-Acquired Infections (epidemiology), Community-Acquired Infections (microbiology), Community-Acquired Infections (virology), Female (MeSH), Gram-Negative Bacterial Infections (epidemiology), Gram-Negative Bacterial Infections (microbiology), Humans (MeSH), Influenza A Virus, H1N1 Subtype (MeSH), Influenza, Human (epidemiology), Influenza, Human (virology), Legionella pneumophila (genetics), Legionella pneumophila (isolation & purification), Male (MeSH), Middle Aged (MeSH), Multiplex Polymerase Chain Reaction (MeSH), Mycoplasma pneumoniae (genetics), Mycoplasma pneumoniae (isolation & purification), Pandemics (MeSH), Pneumonia, Bacterial (diagnosis), Pneumonia, Bacterial (epidemiology), Pneumonia, Bacterial (microbiology), Pneumonia, Viral (diagnosis), Pneumonia, Viral (epidemiology), Pneumonia, Viral (virology), Prospective Studies (MeSH), Respiratory Syncytial Virus Infections (diagnosis), Respiratory Syncytial Virus Infections (epidemiology), Respiratory Syncytial Virus Infections (virology), Respiratory Syncytial Virus, Human (isolation & purification), Respiratory Syncytial Virus, Human (pathogenicity), Seasons (MeSH), Severity of Illness Index (MeSH), Spain (epidemiology).
- MESH :
- geographic , epidemiology : Spain.
- diagnosis : Community-Acquired Infections, Pneumonia, Bacterial, Pneumonia, Viral, Respiratory Syncytial Virus Infections.
- epidemiology : Coinfection, Community-Acquired Infections, Gram-Negative Bacterial Infections, Influenza, Human, Pneumonia, Bacterial, Pneumonia, Viral, Respiratory Syncytial Virus Infections.
- genetics : Bordetella pertussis, Chlamydophila pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae.
- isolation & purification : Bordetella pertussis, Chlamydophila pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae, Respiratory Syncytial Virus, Human.
- microbiology : Coinfection, Community-Acquired Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial.
- pathogenicity : Respiratory Syncytial Virus, Human.
- virology : Coinfection, Community-Acquired Infections, Influenza, Human, Pneumonia, Viral, Respiratory Syncytial Virus Infections.
- Aged, Aged, 80 and over, Bacterial Typing Techniques, Female, Humans, Influenza A Virus, H1N1 Subtype, Male, Middle Aged, Multiplex Polymerase Chain Reaction, Pandemics, Prospective Studies, Seasons, Severity of Illness Index.
Abstract
This study aimed to determine the aetiology of community-acquired pneumonia (CAP) by adding polymerase chain reaction (PCR) to conventional methods and to describe the clinical and laboratory features between patients with bacterial pneumonia (BP) and viral pneumonia (VP). Adults with CAP admitted from November 2009 to October 2010 were included. Demographics, comorbidities, severity and clinical features were recorded. Conventional microbiological methods included blood and sputum cultures, acute and convalescent serologic samples, and antigen urinary detection. New methods included multiplex PCR for Mycoplasma pneumoniae, Legionella pneumophila, Chlamydophila pneumoniae, Bordetella pertussis and 15 respiratory viruses. A total of 169 patients were included. Using conventional methods, we identified a pathogen in 51 % of cases. With PCR, up to 70 % of cases had an aetiological diagnosis. Forty-five patients had BP (34 %), 22 had VP (17 %) and 25 (19 %) had co-infection (BP and VP). Pneumococci and respiratory syncytial virus (RSV) were the most frequently identified pathogens. Procalcitonin (PCT) and C-reactive protein (CRP) median values were significantly higher in BP than in VP patients. Shaking chills, higher CURB score and shock were significantly more frequent in BP. A viral infection was identified in more than one-third of patients with CAP. Clinical and laboratory features could help to differentiate between VP and BP and to guide empirical therapy.
DOI: 10.1007/s10096-012-1626-6
PubMed: 22549730
PubMed Central: PMC7088264
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.</title>
<author><name sortKey="Sangil, A" sort="Sangil, A" uniqKey="Sangil A" first="A" last="Sangil">A. Sangil</name>
<affiliation wicri:level="3"><nlm:affiliation>Service of Internal Medicine, Hospital Universitari Mútua Terrassa, Barcelona, Spain. annasangil@yahoo.com</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Service of Internal Medicine, Hospital Universitari Mútua Terrassa, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Calbo, E" sort="Calbo, E" uniqKey="Calbo E" first="E" last="Calbo">E. Calbo</name>
</author>
<author><name sortKey="Robles, A" sort="Robles, A" uniqKey="Robles A" first="A" last="Robles">A. Robles</name>
</author>
<author><name sortKey="Benet, S" sort="Benet, S" uniqKey="Benet S" first="S" last="Benet">S. Benet</name>
</author>
<author><name sortKey="Viladot, M E" sort="Viladot, M E" uniqKey="Viladot M" first="M E" last="Viladot">M E Viladot</name>
</author>
<author><name sortKey="Pascual, V" sort="Pascual, V" uniqKey="Pascual V" first="V" last="Pascual">V. Pascual</name>
</author>
<author><name sortKey="Cuchi, E" sort="Cuchi, E" uniqKey="Cuchi E" first="E" last="Cuchí">E. Cuchí</name>
</author>
<author><name sortKey="Perez, J" sort="Perez, J" uniqKey="Perez J" first="J" last="Pérez">J. Pérez</name>
</author>
<author><name sortKey="Barreiro, B" sort="Barreiro, B" uniqKey="Barreiro B" first="B" last="Barreiro">B. Barreiro</name>
</author>
<author><name sortKey="Sanchez, B" sort="Sanchez, B" uniqKey="Sanchez B" first="B" last="Sánchez">B. Sánchez</name>
</author>
<author><name sortKey="Torres, J" sort="Torres, J" uniqKey="Torres J" first="J" last="Torres">J. Torres</name>
</author>
<author><name sortKey="Canales, L" sort="Canales, L" uniqKey="Canales L" first="L" last="Canales">L. Canales</name>
</author>
<author><name sortKey="De Marcos, J A" sort="De Marcos, J A" uniqKey="De Marcos J" first="J A" last="De Marcos">J A De Marcos</name>
</author>
<author><name sortKey="Garau, J" sort="Garau, J" uniqKey="Garau J" first="J" last="Garau">J. Garau</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22549730</idno>
<idno type="pmid">22549730</idno>
<idno type="doi">10.1007/s10096-012-1626-6</idno>
<idno type="pmc">PMC7088264</idno>
<idno type="wicri:Area/Main/Corpus">00296</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00296</idno>
<idno type="wicri:Area/Main/Curation">000296</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000296</idno>
<idno type="wicri:Area/Main/Exploration">000296</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.</title>
<author><name sortKey="Sangil, A" sort="Sangil, A" uniqKey="Sangil A" first="A" last="Sangil">A. Sangil</name>
<affiliation wicri:level="3"><nlm:affiliation>Service of Internal Medicine, Hospital Universitari Mútua Terrassa, Barcelona, Spain. annasangil@yahoo.com</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Service of Internal Medicine, Hospital Universitari Mútua Terrassa, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Calbo, E" sort="Calbo, E" uniqKey="Calbo E" first="E" last="Calbo">E. Calbo</name>
</author>
<author><name sortKey="Robles, A" sort="Robles, A" uniqKey="Robles A" first="A" last="Robles">A. Robles</name>
</author>
<author><name sortKey="Benet, S" sort="Benet, S" uniqKey="Benet S" first="S" last="Benet">S. Benet</name>
</author>
<author><name sortKey="Viladot, M E" sort="Viladot, M E" uniqKey="Viladot M" first="M E" last="Viladot">M E Viladot</name>
</author>
<author><name sortKey="Pascual, V" sort="Pascual, V" uniqKey="Pascual V" first="V" last="Pascual">V. Pascual</name>
</author>
<author><name sortKey="Cuchi, E" sort="Cuchi, E" uniqKey="Cuchi E" first="E" last="Cuchí">E. Cuchí</name>
</author>
<author><name sortKey="Perez, J" sort="Perez, J" uniqKey="Perez J" first="J" last="Pérez">J. Pérez</name>
</author>
<author><name sortKey="Barreiro, B" sort="Barreiro, B" uniqKey="Barreiro B" first="B" last="Barreiro">B. Barreiro</name>
</author>
<author><name sortKey="Sanchez, B" sort="Sanchez, B" uniqKey="Sanchez B" first="B" last="Sánchez">B. Sánchez</name>
</author>
<author><name sortKey="Torres, J" sort="Torres, J" uniqKey="Torres J" first="J" last="Torres">J. Torres</name>
</author>
<author><name sortKey="Canales, L" sort="Canales, L" uniqKey="Canales L" first="L" last="Canales">L. Canales</name>
</author>
<author><name sortKey="De Marcos, J A" sort="De Marcos, J A" uniqKey="De Marcos J" first="J A" last="De Marcos">J A De Marcos</name>
</author>
<author><name sortKey="Garau, J" sort="Garau, J" uniqKey="Garau J" first="J" last="Garau">J. Garau</name>
</author>
</analytic>
<series><title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title>
<idno type="eISSN">1435-4373</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Bacterial Typing Techniques (MeSH)</term>
<term>Bordetella pertussis (genetics)</term>
<term>Bordetella pertussis (isolation & purification)</term>
<term>Chlamydophila pneumoniae (genetics)</term>
<term>Chlamydophila pneumoniae (isolation & purification)</term>
<term>Coinfection (epidemiology)</term>
<term>Coinfection (microbiology)</term>
<term>Coinfection (virology)</term>
<term>Community-Acquired Infections (diagnosis)</term>
<term>Community-Acquired Infections (epidemiology)</term>
<term>Community-Acquired Infections (microbiology)</term>
<term>Community-Acquired Infections (virology)</term>
<term>Female (MeSH)</term>
<term>Gram-Negative Bacterial Infections (epidemiology)</term>
<term>Gram-Negative Bacterial Infections (microbiology)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (virology)</term>
<term>Legionella pneumophila (genetics)</term>
<term>Legionella pneumophila (isolation & purification)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Multiplex Polymerase Chain Reaction (MeSH)</term>
<term>Mycoplasma pneumoniae (genetics)</term>
<term>Mycoplasma pneumoniae (isolation & purification)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Bacterial (diagnosis)</term>
<term>Pneumonia, Bacterial (epidemiology)</term>
<term>Pneumonia, Bacterial (microbiology)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Prospective Studies (MeSH)</term>
<term>Respiratory Syncytial Virus Infections (diagnosis)</term>
<term>Respiratory Syncytial Virus Infections (epidemiology)</term>
<term>Respiratory Syncytial Virus Infections (virology)</term>
<term>Respiratory Syncytial Virus, Human (isolation & purification)</term>
<term>Respiratory Syncytial Virus, Human (pathogenicity)</term>
<term>Seasons (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Spain (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Bordetella pertussis (génétique)</term>
<term>Bordetella pertussis (isolement et purification)</term>
<term>Chlamydophila pneumoniae (génétique)</term>
<term>Chlamydophila pneumoniae (isolement et purification)</term>
<term>Co-infection (microbiologie)</term>
<term>Co-infection (virologie)</term>
<term>Co-infection (épidémiologie)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections bactériennes à Gram négatif (microbiologie)</term>
<term>Infections bactériennes à Gram négatif (épidémiologie)</term>
<term>Infections communautaires (diagnostic)</term>
<term>Infections communautaires (microbiologie)</term>
<term>Infections communautaires (virologie)</term>
<term>Infections communautaires (épidémiologie)</term>
<term>Infections à virus respiratoire syncytial (diagnostic)</term>
<term>Infections à virus respiratoire syncytial (virologie)</term>
<term>Infections à virus respiratoire syncytial (épidémiologie)</term>
<term>Legionella pneumophila (génétique)</term>
<term>Legionella pneumophila (isolement et purification)</term>
<term>Mycoplasma pneumoniae (génétique)</term>
<term>Mycoplasma pneumoniae (isolement et purification)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie bactérienne (diagnostic)</term>
<term>Pneumopathie bactérienne (microbiologie)</term>
<term>Pneumopathie bactérienne (épidémiologie)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Réaction de polymérisation en chaine multiplex (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Techniques de typage bactérien (MeSH)</term>
<term>Virus respiratoire syncytial humain (isolement et purification)</term>
<term>Virus respiratoire syncytial humain (pathogénicité)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Community-Acquired Infections</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Syncytial Virus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections communautaires</term>
<term>Infections à virus respiratoire syncytial</term>
<term>Pneumopathie bactérienne</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coinfection</term>
<term>Community-Acquired Infections</term>
<term>Gram-Negative Bacterial Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Bacterial</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Syncytial Virus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Bordetella pertussis</term>
<term>Chlamydophila pneumoniae</term>
<term>Legionella pneumophila</term>
<term>Mycoplasma pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Bordetella pertussis</term>
<term>Chlamydophila pneumoniae</term>
<term>Legionella pneumophila</term>
<term>Mycoplasma pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Bordetella pertussis</term>
<term>Chlamydophila pneumoniae</term>
<term>Legionella pneumophila</term>
<term>Mycoplasma pneumoniae</term>
<term>Respiratory Syncytial Virus, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Bordetella pertussis</term>
<term>Chlamydophila pneumoniae</term>
<term>Legionella pneumophila</term>
<term>Mycoplasma pneumoniae</term>
<term>Virus respiratoire syncytial humain</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Co-infection</term>
<term>Infections bactériennes à Gram négatif</term>
<term>Infections communautaires</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Coinfection</term>
<term>Community-Acquired Infections</term>
<term>Gram-Negative Bacterial Infections</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Respiratory Syncytial Virus, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus respiratoire syncytial humain</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Co-infection</term>
<term>Grippe humaine</term>
<term>Infections communautaires</term>
<term>Infections à virus respiratoire syncytial</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coinfection</term>
<term>Community-Acquired Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Syncytial Virus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Co-infection</term>
<term>Espagne</term>
<term>Grippe humaine</term>
<term>Infections bactériennes à Gram négatif</term>
<term>Infections communautaires</term>
<term>Infections à virus respiratoire syncytial</term>
<term>Pneumopathie bactérienne</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Bacterial Typing Techniques</term>
<term>Female</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multiplex Polymerase Chain Reaction</term>
<term>Pandemics</term>
<term>Prospective Studies</term>
<term>Seasons</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Réaction de polymérisation en chaine multiplex</term>
<term>Saisons</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Techniques de typage bactérien</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This study aimed to determine the aetiology of community-acquired pneumonia (CAP) by adding polymerase chain reaction (PCR) to conventional methods and to describe the clinical and laboratory features between patients with bacterial pneumonia (BP) and viral pneumonia (VP). Adults with CAP admitted from November 2009 to October 2010 were included. Demographics, comorbidities, severity and clinical features were recorded. Conventional microbiological methods included blood and sputum cultures, acute and convalescent serologic samples, and antigen urinary detection. New methods included multiplex PCR for Mycoplasma pneumoniae, Legionella pneumophila, Chlamydophila pneumoniae, Bordetella pertussis and 15 respiratory viruses. A total of 169 patients were included. Using conventional methods, we identified a pathogen in 51 % of cases. With PCR, up to 70 % of cases had an aetiological diagnosis. Forty-five patients had BP (34 %), 22 had VP (17 %) and 25 (19 %) had co-infection (BP and VP). Pneumococci and respiratory syncytial virus (RSV) were the most frequently identified pathogens. Procalcitonin (PCT) and C-reactive protein (CRP) median values were significantly higher in BP than in VP patients. Shaking chills, higher CURB score and shock were significantly more frequent in BP. A viral infection was identified in more than one-third of patients with CAP. Clinical and laboratory features could help to differentiate between VP and BP and to guide empirical therapy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22549730</PMID>
<DateCompleted><Year>2013</Year>
<Month>02</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-4373</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>31</Volume>
<Issue>10</Issue>
<PubDate><Year>2012</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
<ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.</ArticleTitle>
<Pagination><MedlinePgn>2765-72</MedlinePgn>
</Pagination>
<Abstract><AbstractText>This study aimed to determine the aetiology of community-acquired pneumonia (CAP) by adding polymerase chain reaction (PCR) to conventional methods and to describe the clinical and laboratory features between patients with bacterial pneumonia (BP) and viral pneumonia (VP). Adults with CAP admitted from November 2009 to October 2010 were included. Demographics, comorbidities, severity and clinical features were recorded. Conventional microbiological methods included blood and sputum cultures, acute and convalescent serologic samples, and antigen urinary detection. New methods included multiplex PCR for Mycoplasma pneumoniae, Legionella pneumophila, Chlamydophila pneumoniae, Bordetella pertussis and 15 respiratory viruses. A total of 169 patients were included. Using conventional methods, we identified a pathogen in 51 % of cases. With PCR, up to 70 % of cases had an aetiological diagnosis. Forty-five patients had BP (34 %), 22 had VP (17 %) and 25 (19 %) had co-infection (BP and VP). Pneumococci and respiratory syncytial virus (RSV) were the most frequently identified pathogens. Procalcitonin (PCT) and C-reactive protein (CRP) median values were significantly higher in BP than in VP patients. Shaking chills, higher CURB score and shock were significantly more frequent in BP. A viral infection was identified in more than one-third of patients with CAP. Clinical and laboratory features could help to differentiate between VP and BP and to guide empirical therapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sangil</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Service of Internal Medicine, Hospital Universitari Mútua Terrassa, Barcelona, Spain. annasangil@yahoo.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Calbo</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Robles</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Benet</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Viladot</LastName>
<ForeName>M E</ForeName>
<Initials>ME</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pascual</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cuchí</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pérez</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Barreiro</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sánchez</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Torres</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Canales</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>De Marcos</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Garau</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>05</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
<NlmUniqueID>8804297</NlmUniqueID>
<ISSNLinking>0934-9723</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015373" MajorTopicYN="N">Bacterial Typing Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001886" MajorTopicYN="N">Bordetella pertussis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016993" MajorTopicYN="N">Chlamydophila pneumoniae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016905" MajorTopicYN="N">Gram-Negative Bacterial Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016952" MajorTopicYN="N">Legionella pneumophila</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060885" MajorTopicYN="N">Multiplex Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018113" MajorTopicYN="N">Respiratory Syncytial Virus, Human</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>11</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>04</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>5</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>5</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22549730</ArticleId>
<ArticleId IdType="doi">10.1007/s10096-012-1626-6</ArticleId>
<ArticleId IdType="pmc">PMC7088264</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Chest. 2008 Dec;134(6):1141-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18689592</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2008 Feb 9;371(9611):455-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18262027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Postgrad Med. 2010 Mar;122(2):130-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20203464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2008 May 15;46(10):1513-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18419484</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2010 Sep;16(9):1463-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20735934</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>New Microbiol. 2008 Jul;31(3):319-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18843885</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2005 Aug 1;41(3):345-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16007532</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Jan;41(1):63-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12517826</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2010 Oct;138(4):811-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20363845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Infect Dis. 2009 Apr;22(2):143-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19276881</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2011 Apr 9;377(9773):1264-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21435708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Chronic Dis. 1987;40(5):373-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Infect Dis. 2009;41(1):45-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18821175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17278083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Chemother. 2006 Apr;12(2):63-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16648944</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Jan 15;50(2):202-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20014950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2011 Jul 15;53(2):107-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21690616</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2008 Jul;63(7):658-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18587038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2003 May;58(5):377-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12728155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2010 Jul;48(7):2325-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20421436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antivir Ther. 2006;11(3):351-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16759052</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2011 May;52 Suppl 4:S346-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21460294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2008 Jan;63(1):42-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17573440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Dec 13;362(9400):1991-2001</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14683661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1997 Jan 23;336(4):243-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8995086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Apr;42(4):1564-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15071005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Anti Infect Ther. 2010 May;8(5):575-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20455686</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2011 May;37(5):1151-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20817703</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Infect Dis. 2008;40(2):131-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17852937</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Infect Dis. 2011 Aug;43(8):609-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21466255</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Barreiro, B" sort="Barreiro, B" uniqKey="Barreiro B" first="B" last="Barreiro">B. Barreiro</name>
<name sortKey="Benet, S" sort="Benet, S" uniqKey="Benet S" first="S" last="Benet">S. Benet</name>
<name sortKey="Calbo, E" sort="Calbo, E" uniqKey="Calbo E" first="E" last="Calbo">E. Calbo</name>
<name sortKey="Canales, L" sort="Canales, L" uniqKey="Canales L" first="L" last="Canales">L. Canales</name>
<name sortKey="Cuchi, E" sort="Cuchi, E" uniqKey="Cuchi E" first="E" last="Cuchí">E. Cuchí</name>
<name sortKey="De Marcos, J A" sort="De Marcos, J A" uniqKey="De Marcos J" first="J A" last="De Marcos">J A De Marcos</name>
<name sortKey="Garau, J" sort="Garau, J" uniqKey="Garau J" first="J" last="Garau">J. Garau</name>
<name sortKey="Pascual, V" sort="Pascual, V" uniqKey="Pascual V" first="V" last="Pascual">V. Pascual</name>
<name sortKey="Perez, J" sort="Perez, J" uniqKey="Perez J" first="J" last="Pérez">J. Pérez</name>
<name sortKey="Robles, A" sort="Robles, A" uniqKey="Robles A" first="A" last="Robles">A. Robles</name>
<name sortKey="Sanchez, B" sort="Sanchez, B" uniqKey="Sanchez B" first="B" last="Sánchez">B. Sánchez</name>
<name sortKey="Torres, J" sort="Torres, J" uniqKey="Torres J" first="J" last="Torres">J. Torres</name>
<name sortKey="Viladot, M E" sort="Viladot, M E" uniqKey="Viladot M" first="M E" last="Viladot">M E Viladot</name>
</noCountry>
<country name="Espagne"><region name="Catalogne"><name sortKey="Sangil, A" sort="Sangil, A" uniqKey="Sangil A" first="A" last="Sangil">A. Sangil</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000342 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000342 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeEspagneV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:22549730 |texte= Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22549730" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeEspagneV1
This area was generated with Dilib version V0.6.37. |